Skip to main content

Are you Dr. Urbanski?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 5 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Summary

  • Dr. Raymond Urbanski, MD is an internist in Calabasas, California. He is currently licensed to practice medicine in Pennsylvania.

Education & Training

  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 1992

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1996 - 2022

Press Mentions

  • PharmaEssentia Initiates Phase 3b Trial of Ropeginterferon Alfa-2b-Njft Investigatng New Dosing Regimen for Patients with Polycythemia Vera (PV)
    PharmaEssentia Initiates Phase 3b Trial of Ropeginterferon Alfa-2b-Njft Investigatng New Dosing Regimen for Patients with Polycythemia Vera (PV)May 3rd, 2023
  • Clinical Review of Ropeginterferon Alfa-2b Suggests Amended Dosing Schedule May Support Improved Clinical Outcomes in Polycythemia Vera
    Clinical Review of Ropeginterferon Alfa-2b Suggests Amended Dosing Schedule May Support Improved Clinical Outcomes in Polycythemia VeraFebruary 2nd, 2023
  • NCCN Clinical Practice Guidelines in Oncology Update Recommends BESREMi® (Ropeginterferon Alfa-2b-Njft) for the Treatment of Polycythemia Vera
    NCCN Clinical Practice Guidelines in Oncology Update Recommends BESREMi® (Ropeginterferon Alfa-2b-Njft) for the Treatment of Polycythemia VeraMarch 2nd, 2022
  • Join now to see all